Weill Cornell Medicine Oncology & Hematology
Playback speed
10 seconds
ASH 2021: Comparing Outcomes Between CPX-351 and HMA+Ven As 1L Therapy in AML
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
Pinkal Desai
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
Pinkal Desai
102 views
December 23, 2021
Comments 0
Login to view comments.
Click here to Login